EpiQuil co-founder awarded CERI Women in Business Scholarship

EpiQuil co-founder and CEO Hélène Klein was awarded the CERI Women in Business Scholarship, recognising her entrepreneurial ambitions and leadership in life sciences. The scholarship supports her continued development as a founder and the advancement of EpiQuil's pharmaceutical innovation platform.

Previous
Previous

EpiQuil receives ethics approval for preclinical pharmacokinetic study

Next
Next

EpiQuil selected for the UNSW Health10x 2026 Accelerator